Archive: Patient Recruitment

Patient recruitment is one of the most critical and challenging aspects of clinical trials. Medical contact centers can be beneficial to the entire healthcare industry, but we’re going to focus on how they can help clinical trial participation. These contact centers drive study enrollment by improving the patient recruitment process through patient engagement and education.

When it comes to recruiting patients for clinical trials in rare diseases, HCP outreach and support is essential. Most trials in the rare disease space struggle with patient recruitment unless they have a well thought out strategy on how to include HCPs in the recruitment process. 

Imagine a patient participating in a clinical trial for a new vaccine. They take a half day of PTO to visit the clinic, which is a short 15-minute drive from their home. After an hour visit, they are given $50 as compensation – a reasonable amount which they spend on a nice dinner. This describes

For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers

At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been affected. As the coronavirus pandemic continues, we continue to see how the rapidly evolving situation is also changing the clinical trial landscape. The third round of our survey was

SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory health conditions by screening for multiple studies at once. And now we’re taking our marketplace one step further. In February 2022, SubjectWell expanded our proven clinical trial marketplace to

Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like slowness of movement, gait problems, rigidity, and tremors, as well as significant “invisible” non-motor symptoms, cognitive problems, anxiety, depression, sleep disorders, and digestive problems, which can be disabling. Within

In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and control symptoms, while pharmaceutical companies quest for new or improved treatments and drug combinations. To better understand patient attitudes toward their breathing problems or asthma diagnosis – along with

The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our team at SubjectWell decided to make use of our connections to both research sites and patients. We set out to assess what adjustments sites have made to their operations,

In honor of American Heart Month, let’s take a look at how sponsors and CROs can optimize patient outreach strategies and boost recruitment for heart disease clinical trials.